Company: MDCXW
Filing Date: 2025-06-30
Form Type: DEF 14A
Source: 0001062993-25-012273
Chunk: 37

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-30
Form: DEF 14A
Chunk 37
---
 a timely or cost-effective manner if such financing would otherwise be subject to the Exchange Cap. This limitation could restrict our ability to obtain full financing under the SEPA. Failure to obtain sufficient financing may result in the delay or indefinite postponement of our business plans. We could be forced to rely on alternative, potentially less attractive funding structures or reduce the scale and timing of our growth initiatives.

Shareholder Approval

The Board recommends that Shareholders vote in favor of the following share issuance resolution at the Meeting (the "Share Issuance Resolution").

"RESOLVED, as an ordinary resolution of the shareholders of Medicus Pharma Ltd., that the issuance, sale and delivery by the Company pursuant to the Standby Equity Purchase Agreement dated February 10, 2025 between the Company and YA II PN, Ltd. of Common Shares representing 20% or more of the issued and outstanding Common Shares prior to such issuance at prices below the minimum price specified by Nasdaq Listing Rule 5635(d) is hereby approved in accordance with such rule."

<div align='center'>- 30 -</div>

In order to pass the Share Issuance Resolution, at least a majority of the votes cast by the Shareholders present at the Meeting in person or by proxy must be voted in favor of the Share Issuance Resolution.

THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE "" THE QUORUM AMENDMENT IN PROPOSAL 4.

<div align='center'>PROPOSAL 5 - ARTICLES OF AMENDMENT</div>

At present, a simple majority of the Board is sufficient to remove the duly elected Chairman of the Board. The Board believes it is in the best interest of the Shareholders to increase the voting threshold required to remove the Chairman of the Board to a vote of at least 75% of the Board and to make this provision part of the Articles. The Board believes that continuity in the Chairman of the Board is important to the Company's development and believes that a 75% threshold provides the appropriate assurance of continuity. The Board wishes to put this provision in the Articles so that Shareholders voting by special resolution are the body that has ultimate control over the amendment or removal of this provision.

The Board wishes to amend the Articles to provide that the director who is elected Chairman of the Board following the Meeting shall remain Chairman of the Board as long as he or she remains a director, unless he or she (i) resigns as Chairman of the Board or (ii) is removed as Chairman of